Read + Share
Amedeo Smart
Independent Medical Education
Alves C. Orismilast for moderate-to-severe atopic dermatitis: the potential therapeutic value of a new oral pharmacological alternative. Br J Dermatol 2025 Jan 30:ljaf042. doi: 10.1093.PMID: 39880395
Email
LinkedIn
Privacy Policy